Press releases
Read more:
Categories
2026
2026-01-30 08:22
NOTICE OF EXTRAORDINARY GENERAL MEETING IN NANOLOGICA AB (PUBL)
The shareholders of Nanologica AB (publ), org.nr 556664-5023 (the "Company") are hereby invited to attend the Extraordinary General Meeting to...
2026-01-30 08:16
NANOLOGICA CARRIES OUT DIRECTED SHARE ISSUES OF APPROX. SEK 13.7 MILLION IN TOTAL, AND A FULLY SECURED RIGHTS ISSUE OF APPROX. SEK 82.5 MILLION
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND...
2026-01-29 18:07
Nanologica AB (publ) Acquires Ardena Södertälje AB
Nanologica AB (publ) ("Nanologica") has today entered into an agreement and completed the acquisition of all shares in Ardena Södertälje...
2025
Nanologica has received an order for a non-silica-based purification media from a customer in Asia. The order value amounts to approximately SEK 1.5 million...
2025-10-23 08:10
Interim Report Q3 2025 Nanologica AB (publ)
FINANCIAL SUMMARY EVENTS DURING THE THIRD QUARTER EVENTS AFTER THE END OF THE PERIOD COMMENT FROM THE CEOWith stable production and a first order on the...
2025-10-22 09:41
Nanologica AB (publ) Receives Order of appx. SEK 1 Million In China
Nanologica has received an order for the company's silica-based purification media NLAB Saga® from a new distribution partner in China. The order...
2025-10-16 16:34
Nanologica AB (publ) Receives Additional Order of approx. SEK 2.7 Million from Customer in the US
Nanologica has received a supplementary order for the company's silica-based purification media NLAB Saga® from a customer in the US who placed...
In accordance with the current nomination committee instructions, the chairman of the board has contacted Nanologica's three largest shareholders...
2025-10-01 09:55
Nanologica AB (publ) Enters the Insulin Market in China
Nanologica has entered the insulin market in China with an order of approximately SEK 2 million for the company's silica-based purification media...
2025-07-10 08:10
Interim Report Q2 2025 Nanologica AB (publ)
FINANCIAL SUMMARY EVENTS DURING THE SECOND QUARTER CEO COMMENTAs expected, the second quarter was not as strong in terms of sales as the first. However...